Kerin MJ - Search Results

1

Screening of exosomal microRNAs from colorectal cancer cells.

Clancy C, Khan S, Glynn CL, Holian E, Dockery P, Lalor P, Brown JA, Joyce MR, Kerin MJ, Dwyer RM. Clancy C, et al. Among authors: kerin mj. Cancer Biomark. 2016;17(4):427-435. doi: 10.3233/CBM-160659. Cancer Biomark. 2016. PMID: 27802194

2

Monocyte chemotactic protein-1 secreted by primary breast tumors stimulates migration of mesenchymal stem cells.

Dwyer RM, Potter-Beirne SM, Harrington KA, Lowery AJ, Hennessy E, Murphy JM, Barry FP, O'Brien T, Kerin MJ. Dwyer RM, et al. Among authors: kerin mj. Clin Cancer Res. 2007 Sep 1;13(17):5020-7. doi: 10.1158/1078-0432.CCR-07-0731. Clin Cancer Res. 2007. PMID: 17785552

3

MicroRNAs as prognostic indicators and therapeutic targets: potential effect on breast cancer management.

Lowery AJ, Miller N, McNeill RE, Kerin MJ. Lowery AJ, et al. Among authors: kerin mj. Clin Cancer Res. 2008 Jan 15;14(2):360-5. doi: 10.1158/1078-0432.CCR-07-0992. Clin Cancer Res. 2008. PMID: 18223209 Review.

4

Potential role of mesenchymal stem cells (MSCs) in the breast tumour microenvironment: stimulation of epithelial to mesenchymal transition (EMT).

Martin FT, Dwyer RM, Kelly J, Khan S, Murphy JM, Curran C, Miller N, Hennessy E, Dockery P, Barry FP, O'Brien T, Kerin MJ. Martin FT, et al. Among authors: kerin mj. Breast Cancer Res Treat. 2010 Nov;124(2):317-26. doi: 10.1007/s10549-010-0734-1. Epub 2010 Jan 20. Breast Cancer Res Treat. 2010. PMID: 20087650

5

Mesenchymal stem cells and cancer: tumor-specific delivery vehicles or therapeutic targets?

Dwyer RM, Kerin MJ. Dwyer RM, et al. Among authors: kerin mj. Hum Gene Ther. 2010 Nov;21(11):1506-12. doi: 10.1089/hum.2010.135. Epub 2010 Oct 6. Hum Gene Ther. 2010. PMID: 20649487 Review.

6

MicroRNAs in colorectal cancer: function, dysregulation and potential as novel biomarkers.

Nugent M, Miller N, Kerin MJ. Nugent M, et al. Among authors: kerin mj. Eur J Surg Oncol. 2011 Aug;37(8):649-54. doi: 10.1016/j.ejso.2011.05.005. Epub 2011 May 31. Eur J Surg Oncol. 2011. PMID: 21632200 Free article. Review.

7

Relationship between CCL5 and transforming growth factor-β1 (TGFβ1) in breast cancer.

Hartmann MC, Dwyer RM, Costello M, Potter SM, Curran C, Hennessy E, Newell J, Griffin DG, Kerin MJ. Hartmann MC, et al. Among authors: kerin mj. Eur J Cancer. 2011 Jul;47(11):1669-75. doi: 10.1016/j.ejca.2011.05.001. Epub 2011 Jun 12. Eur J Cancer. 2011. PMID: 21658938

8

A review of expression profiling of circulating microRNAs in men with prostate cancer.

Kelly BD, Miller N, Healy NA, Walsh K, Kerin MJ. Kelly BD, et al. Among authors: kerin mj. BJU Int. 2013 Jan;111(1):17-21. doi: 10.1111/j.1464-410X.2012.11244.x. Epub 2012 May 22. BJU Int. 2013. PMID: 22612403 Review.

9

Systemic mirnas as potential biomarkers for malignancy.

Healy NA, Heneghan HM, Miller N, Osborne CK, Schiff R, Kerin MJ. Healy NA, et al. Among authors: kerin mj. Int J Cancer. 2012 Nov 15;131(10):2215-22. doi: 10.1002/ijc.27642. Epub 2012 Jul 30. Int J Cancer. 2012. PMID: 22618667 Free article. Review.

10

Circulating miR-34a levels are reduced in colorectal cancer.

Nugent M, Miller N, Kerin MJ. Nugent M, et al. Among authors: kerin mj. J Surg Oncol. 2012 Dec;106(8):947-52. doi: 10.1002/jso.23174. Epub 2012 May 30. J Surg Oncol. 2012. PMID: 22648208

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

396 results

Search Page